Prevalence of hepatitis b virus in patients with diabetes mellitus: A comparative cross sectional study at woldiya general hospital, Ethiopia

Pan African Medical Journal

Volumn 17, Issue , 2014, Pages

  Mekonnen, Daniel ^a,b   Gebre Selassie, Solomon ^b   Fantaw, Surafel ^c   Hunegnaw, Andualem ^d   Mihret, Adane ^b,e  

^a Bahir Dar Regional Health Research Laboratory Center   (Ethiopia)

^b ADDIS ABABA UNIVERSITY   (Ethiopia)

^c ETHIOPIAN PUBLIC HEALTH INSTITUTE   (Ethiopia)

^d Amhara National Regional State Health Bureau   (Ethiopia)

^e ARMAUER HANSEN RESEARCH INSTITUTE   (Ethiopia)

Author keywords

Association; Diabetes; Hbv; Non diabetes; Prevalence

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTICLE; CHRONIC LIVER DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ETHIOPIA; FEMALE; HEPATITIS B; HEPATITIS B RAPID TEST; HUMAN; INFECTION RISK; INSULIN DEPENDENT DIABETES MELLITUS; INVASIVE PROCEDURE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; ADOLESCENT; COMPLICATION; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HEPATITIS B VIRUS; ISOLATION AND PURIFICATION; MIDDLE AGED; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ETHIOPIA; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 84893054277     PISSN: 19378688     EISSN: None     Source Type: Journal    
DOI: 10.11604/pamj.2014.17.40.2465     Document Type: Article

References (27)

1. A professional's guide to hepatitis B. British Liver Trust 2009. Southampton Road and Ringwood, BH24 1HY.
2. Lok ASF and McMahon B.J. Chronic Hepatitis B: Update. American Association for the Study of Liver Diseases (AASLD) Practice Guidelines Hepatology. 2009; 50 (3): 1-36.
3. Edmunds WJ, Medley GF, Nokes DJ, O'callaghan C J, Whittle HC, Hall AJ. Epidemiological Patterns of Hepatitis B Virus in Highly Endemic Areas. Epidemiol Infect.1996; 117(2):313-325.
4. WHO. Department of communicable diseases surveillance and response. 2002. Hepatitis B. Online available from http://www.who.int/emt. Accessed on June 23, 2012.
5. Abebe A, Nokes J, Dejene A, Enquselassie F, Messele T, Cutts T. Seroepidemiology of hepatitis B virus in Addis Ababa Ethiopia: transmission patterns and vaccine control. Epidemiol Infect. 2003; 131(1): 756-770.
6. Kefenie H, Rapicetta M, Rossi G B, Bisanti L, Bekura D, Morace G, Palladino P, Rienzo A D, Conti S, Bassani F, Bertolaso G, Pasquini P. A nationwide seroepidemiological study of hepatitis B markers prevalence was conducted in Ethiopia on 5,270 young males from all regions of the country. Journal of Medical Virology. 2005; 24(1): 75-84.
7. Pasquini P, Bisanti L, Soldo L, Palladino P, Rozera C, Frontini E, Miozzo A, Di Gennaro TM, Indi A, Conti S, et al. Hepatitis B infections in the Arsi region of Ethiopia. Eur J Epidemiol.1988; 4(3):310-313.
8. Shimelis T, Torben W, Medhin G, Tebeje M, Andualm A, Demessie F, Mulu A, Tegbaru B and Gebre-Selassie S. Hepatitis B virus infection among attendants of VCT and ART clinic of Saint Paul's General Specialized Hospital, Addis Ababa, Ethiopia. Sex Transm Infect. 2007; 84(1):37-41.
9. Tessema B, Yismaw G, Kassu A, Amsalu A, Mulu A, Emmrich F, Sack U. Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years. BMC Infectious Diseases. 2010; 10(111):1-7.
10. Negero A, Sisay Z, Medhin G. Prevalence of Hepatitis B surface antigen (HBsAg) among visitors of Shashemene General Hospital voluntary counseling and testing center. BMC Research Notes. 2011; 4 (35):1-5.
11. Won Yoon J and Sook Jun H. Diabetes Mellitus: A Fundamental and Clinical Text.3rd Edition. 2004. Lippincott Williams & Wilkins.
12. Halota W, Muszynska M, Pawlowska M. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes. Med Sci Monit. 2002; 8(7):516-519.
13. Thompson Nicola D., and Perz Joseph F. Eliminating the Blood: Ongoing Outbreaks of Hepatitis B Virus Infection and the Need for Innovative Glucose Monitoring Technologies. Journal of Diabetes Science and Technology. 2009; 3(2):283-288.
14. Physician's guide to Hepatitis B a silent killer. 2007. Asian Liver Center at Stanford University.
15. Judi L, Toukan A, Khader Y, Ajlouni K, and Khatib M. Prevalence of elevated hepatic transaminases among Jordanian patients with type 2 diabetes mellitus. Ann Saudi Med. 2010; 30 (1): 25-32.
16. Sheth S.G, and Chopra S. Pathogenesis, clinical features, and diagnosis of nonalcoholic steatohepatitis. Uptodate. 2010;18(2):1-8.
17. David M, Peter M. Fields Virology. 5th Edition. 2007. Lippincott Williams & Wilkins. 2978-3014.
18. Murray P R, Rosenthal K S, Pfaller M A. Medical Microbiology.5th ed. 2005. Elsevier Mosby.
19. Sharma S.K, Saini N, Chwla Y. Hepatitis B Virus: Inactive carriers. Virology Journal. 2005; 2 (82):1-5.
20. Fauci Braunwald, Kasper Hauser, Longo Jameson, Loscazo. Harrison's Principles of Internal Medicine. Seventeenth Edition. 2008. The McGraw-Hill Companies, Inc.
21. Blonski W, Kotlyar D S, Forde K A. Non-viral causes of hepatocellular carcinoma. World J Gastroenterol. 2010; 16(29): 3603-3615.
22. El-Ottol A, Elmanama A, Ayesh B. Prevalence and risk factors of hepatitis B and C viruses among haemodialysis patients in Gaza strip, Palestine. Virology Journal. 2010; 7: 210.
23. Chen H-F, Yi Li Ch, Chen P, Ting T, Yu Lee H. Seroprevalence of Hepatitis B and C in Type 2 Diabetic Patients. J Chin Med Assoc. 2006; 69(4):146-152.
24. Kew MC, Mackay M E, Mindel A, Joffe B, Kusman B, Macnab G M, Seftel H C. Prevalence of Hepatitis B Surface Antigen and Antibody in White and Black Patients with Diabetes Mellitus. Journal of Clinical Microbiology. 2001; 4(6): 467-469.
25. Kilic D, Kaygusuz S, Agalar C, Guliter S, Cakmak A and Sezikli M. HGV prevalence in patients with Type II diabetes mellitus and HGV infection. J Infect Developing Countries. 2007; 1(2):189-194.
26. Onyekwere CA, Anomneze EE, Wali S. Prevalence of serological markers of chronic hepatitis B virus infection in diabetics in the Lagos University Teaching Hospital, Lagos. Niger Postgrad Med J. 2002; 9(3): 129-133.
27. Gulcan A, Gulcan E, Toker A, Bulut I, Akcan Y. Evaluation of risk factors and seroprevalence of hepatitis B and C in diabetic patients in Kutahya, Turkey. J Investig Med.2008;56(6):858-863.